Effects of warm blood cardioplegic solution on myocardial protection

Abstract

To evaluate the effects of warm blood cardioplegic solution on myocardial protection, normothermic induction and terminal perfusion of oxygenated blood cardioplegia in combination with intermittent administration of cold blood cardioplegia during ischemia were studied in an isolated working rat heart model. The experimental protocol consisted of a 120 min cardioplegic arrest followed by 45 min normothermic reperfusion. Myocardial content of adenosine triphosphate (ATP), recovery of the left ventricular function, release of creatine phosphokinase (CPK) and ultrastructure of myocardium were assessed before and after ischemia. The results showed that the hearts preserved with warm blood cardioplegic induction and terminal perfusion had significantly higher levels of ATP, better recovery of cardiac function and lower releases of CPK than those receiving cold blood cardioplegia alone, with myocardial tissue being of generally normal structure. These findings suggest that warm induction and terminal perfusion of blood cardioplegic solution can accelerate myocardial metabolic and functional recovery, preserve high-energy phosphate, reduce myocardial injury and enhance myocardial protection.

Keywords

warm blood cardioplegic solution / cold blood cardioplegic solution / myocardial protection

References

[1] HammonJ W, GrahamT P, BoucekR J, et al.. Myocardial adenonine triphosphate content as a measure of metabolic and functional myocardial protection in children undergoing cardiac operation. Ann Thorac Surg., 1987, 44: 467-467

[2] KaoR L, MagovernG J. Prevention of reperfusional damage from ischemic myocardium. J Thorac Cardiovasc Surg, 1986, 91: 106-106

[3] TeohK H, ChristakisG T, WeiselR D, et al.. Accelerated myocardial metabolic recovery with warm blood cardioplegia. J Thorac Cardiovasc Surg, 1986, 91: 888-888

[4] BarnerH B, KaiserG C, CoddJ E, et al.. Clinical experience with cold blood as the vehicle for hypothermic potassium cardioplegia. Ann Thorac Surg, 1980, 29: 224-224

[5] HendrenW G, O’KeefeD D, GeffinG A, et al.. Maximal oxygenation of dilute blood cardioplegic solution. Ann Thorac Surg, 1987, 44: 48-48

[6] MagovernG J, FlahertyJ J, GottV L. Failure of blood cardioplegia to protect myocardium at lower temperatures. Circulation, 1982, 66: I-I

[7] MartinD R, ScottD F, DownesG L, et al.. Primary cause of unsuccessful liver and heart preservation: cold sensitivity of the ATPase system. Ann Surg, 1972, 175: 111-111

[8] MrakR E, CarryM M, MurphyM I, et al.. Reperfusion injury in ischemic myocardium: protective effect of controlled reperfusion. Am J Cardiovasc Pathol, 1990, 3: 217-217

[9] DewittD F, JochimK E, BehrendtD M. Nucleotide degradation and functional impairment during cardioplegia: Amelioration by inosine. Circulation, 1983, 67: 171-171

[10] WyattD A, ElyS W, LasleyR D, et al.. Purineenriched asanguineous cardioplegia retards adenosine triphosphate degradation during ischemia and improves post.schemic ventricular function. J Thorac Cardiovasc Surg, 1989, 97: 771-771

[11] FolleteD M, FeyK, BuckergG D, et al.. Reducing postischemic damage by temporary modification of reperfusate calcium, potassium, pH, and osmolarity. J Thorac Cardiovasc Surg, 1981, 82: 221-221

[12] LazarH L, BuckbergG D, ManganaroA J, et al.. Reversal of ischemic damage with secondary blood cardioplegia. J Thorac Cardiovasc Surg, 1979, 78: 688-688

[13] JuliaP L, BuckbergG D, AcarS, et al.. Studies of controlled reperfusion after ischemia. X X I. Reperfusion composition: Superiorty of blood cardioplegia over crystalloid cardioplegia in limiting reperfusion damageImportance of endogenous oxygen free radical scavengers in red blood cells. J Thorac Cardiovasc Surg, 1991, 101: 303-303